CELLmeric
CELLmeric
  • Home
  • About us
  • Solutions
  • 首頁
  • 關於我們
  • 解決方案
  • 更多
    • Home
    • About us
    • Solutions
    • 首頁
    • 關於我們
    • 解決方案
  • Home
  • About us
  • Solutions
  • 首頁
  • 關於我們
  • 解決方案

ABOUT US

CELLmeric is a CUHK spin-off biotech company based on a core innovation “Virus-Free Gene Delivery System”, which highly preserve the genomic integrity and viability of the produced cells due to our low energy-based gene engineering platform.


We have successful generated safe and effective CAR-T cells with stable gene modification and superior anticancer activity; providing the first-in-class cell therapy for cancer, inflammatory diseases, and beyond. 

Virus-Free Cell Engineering System

  By using our patented low energy gene delivery system, we can mass produce safe and effective 

CAR-T/NK cells for immunotherapy without the use of virus.

Learn more about our solutions

High Recognition

Our innovative technology has received widespread recognition through awards and social media

Awards

2025: 

Winner of START-UP EXPRESS (HKTDC)
Silver Medal in Inventions Geneva 2025 (Swiss)
2024: 

Gold Prize of China International College Students’ Innovation Competition 2024
Silver Medal in Inventions Geneva 2024 (Swiss)
2023: 

Bronze Medal in the 13th IIFME – International Invention Fair of the Middle East
2022: 

Bronze Medal at the Inventions of Geneva 2022 (Switzerland)
2021: 

Gold Medal with Congratulations of the Jury Medal in Inventions Geneva 2021 (Switzerland)
7th Youth Dream Makers 2021 (Hong Kong) 

Contact us

CELLmeric Limited

Unit 501, 5/F, Belgian Bank Building, 721-725 Nathan Road, Mongkok

info@cellmeric.com

We Welcome Your Messages!

取消

CELLmeric Limited

Copyright © 2025 CELLmeric — 保留所有權利。

此網站使用 cookie。

我們會使用 cookie 分析網站流量，並為您最佳化網站的使用體驗。您接受我們使用 cookie，即表示您的資料會和其他使用者的資料進行整合。

接受